PALM SPRINGS, Fla.–(BUSINESS WIRE)–My Eyelab, a retail brand of Now Optics, is staying true to its vision of modernizing the eye care experience for all people and making franchising easy. 2020 has already proven immense growth for the brand with 23 …
Author: Business Wire
Leo Lens Pharma Expands Its Scientific Advisory Board
SAN DIEGO–(BUSINESS WIRE)–Leo Lens Pharma Expands Its Scientific Advisory Board
Eyenuk Announces FDA Clearance for EyeArt Autonomous AI System for Diabetic Retinopathy Screening
LOS ANGELES–(BUSINESS WIRE)– #FDA–Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, announced today that it has received 510(k) clearance (K200…
IVERIC bio Reports Second Quarter 2020 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–IVERIC bio today announced the financial and operating results for the fiscal quarter ended June 30, 2020 and provided a general business update.
Ophthalmology Times® Opens Voting for the 2020 Resident Writers Award Program
CRANBURY, N.J.–(BUSINESS WIRE)–Ophthalmology Times® Opens Voting for the 2020 Resident Writers Award Program
World Retinal Biologics Market: Growth, Trends and Forecasts (2020-2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Biologics Market – Growth, Trends, and Forecasts (2020-2025)” report has been added to ResearchAndMarkets.com’s offering. The Global Retinal Biologics Market studied is anticipated to grow with a CAGR of nearly 6.8…
IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced Pravin Dugel, MD will present an overview of the Company at the Wedbush PacGrow Healthcare Virtual Conference on Aug. 12, 2020.
Kala Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present a…
Global Glaucoma Surgery Devices Market 2020-2025: Focus on Glaucoma Drainage Devices, Laser Systems, Punches, Probes, and Other Products – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Glaucoma Surgery Devices Market – Growth, Trends, and Forecasts (2020-2025)” report has been added to ResearchAndMarkets.com’s offering. The Global Glaucoma Surgery Devices Market is expected to register a CAGR of 6.5% dur…
Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat at the BTIG …
Gyroscope Announces Appointment of Leaders in Retinal Disease, Gene Therapy and the Complement System to Its Clinical and Scientific Advisory Boards
LONDON–(BUSINESS WIRE)–Gyroscope announces appointment of leaders in retinal disease, gene therapy and the complement system to its Clinical and Scientific Advisory Boards.
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–IVERIC bio reported that the Company granted Dhaval Desai, Chief of Staff, equity based awards pursuant to the 2019 Inducement Stock Incentive Plan.
National Wildlife Refuge, State Park and City Offer Scenic Viewers Adapted for Color Blindness from EnChroma and SeeCoast
BERKELEY, Calif. & FAIRHOPE, Ala.–(BUSINESS WIRE)– #CityofSandyOR–National Wildlife Refuge in Florida, Georgia State Park and Oregon City to Offer Scenic Viewers Adapted for Color Blindness from EnChroma and SeeCoast
New Topline TEPEZZA® (teprotumumab-trbw) Data Underscore its Efficacy in Longer Disease Duration, Long-Term Durability and Potential for Retreatment in People Living with Thyroid Eye Disease (TED)
DUBLIN–(BUSINESS WIRE)–Horizon announced topline data adding to the growing body of evidence supporting the efficacy and safety of TEPEZZA for Thyroid Eye Disease (TED).
Ocular Therapeutix™ To Report Second Quarter 2020 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
I LED a spettro naturale della serie SunLike di Seoul Semiconductor adottati da un marchio tradizionale giapponese per l’illuminazione delle camerette dei ragazzi per favorire la concentrazione e l’apprendimento degli studenti
ANSAN, Corea del Sud–(BUSINESS WIRE)–Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), importante azienda globale produttrice di semiconduttori compositi, ha reso noto che i propri LED a spettro naturale della serie SunLike sono stati scelti da KOIZUMI …
Les LED à spectre naturel de la série SunLike de Seoul Semiconductor sont adoptées par une marque japonaise traditionnelle pour l’éclairage des chambres d’enfants afin de favoriser l’apprentissage et la concentration des élèves
ANSAN, Corée du Sud–(BUSINESS WIRE)–Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), un leader mondial des semi-conducteurs composites, a annoncé que les diodes électroluminescentes (Light Emitting Diodes, LED) à spectre naturel de sa série SunLike ont…
Vollspektrum-LEDs der SunLike-Serie von Seoul Semiconductor werden von traditioneller japanischer Marke für Kinderzimmerbeleuchtung eingesetzt – Förderung von Lernerfolg und Konzentration von Schülern
ANSAN, Südkorea–(BUSINESS WIRE)–Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), ein weltweit führender Anbieter von Verbindungshalbleitern, hat bekanntgegeben, dass seine Vollspektrum-LEDs der SunLike-Serie von KOIZUMI Lighting Technology Corp. („Koiz…
Kala Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference Call
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report se…
Tanner Pharma Group and Dompé Initiate Distribution Partnership for Oxervate®
MILAN & CHARLOTTE, N.C.–(BUSINESS WIRE)–Tanner Pharma Group and Dompé Initiate Distribution Partnership for Oxervate®